Australia's largest stock trading and investment forum Australia's #1 stock forum

Short Term Trading Week Starting: 29 Jun, page-55

First 55 Last

Share
Profile

Follow
dazatoN

8,187 Posts.

487

30/06/20

23:01

Post #: 45552065
Share

Originally posted by dazatoN: ↑

ATH could be the next ESK tomorrow

ATH-The most undervalued Biotech on the ASX
- Just announced today that ithas received guidance from (FDA) in relation to the development pathway for ATH434 (previously PBT434), the company’s lead compound for the treatment of Multiple System Atrophy (MSA), a Parkinsonian disorder.
- The company recently met with the FDA following thesuccessful completion of its Phase 1 clinical trial last year
-No current treatments for Parkinsons
- “The FDA clearly recognizes the seriousness of MSA and the need for new treatments to address this devastating Orphan disease. Our pre-IND meeting was very collegial."
-“Because we’re treating the underlying cause of disease by targeting alpha synuclein, I think we have potential to affect all aspects of disease — the motor symptoms, the blood pressure problems, gait and balance, and even bowel and bladder dysfunction."

- 10.4mill cash, 16mill market cap
- Top 20 hold 88%, extremely tightly held. There are some big names on register who dont care about short term price movements, but rather believe in the science. Worth mentioning that suffering shareholders have been holding ATH for years, they too believe in the science.
-Life Biosciences LLC have invested $12mill at 3.9c last year

Chart says it all, we could get another stellar run in 2013 when it went from 10c to $1.40. Stock has been doing nothing for decades, what a base
Im guessing tomorrow is the beginning of that stellar run.
Currently up 200% on NASDAQ.

Expand

Seems to be getting much traction in the US, huge news coverage

https://www.streetinsider.com/PRNewswire/Alterity+Therapeutics+meeting+with+US+FDA+provides+development+pathway+for+ATH434/17060860.html

https://alphastocknews.com/alterity-therapeutics-athe-stock-rockets-on-fda-news/3666/

Last edited by dazatoN: 30/06/20
6 Upvote

2 Great analysis

Reply

Top Stories

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

HotCopper Highlights: Your most watched and most discussed stocks this week

Trump is President Again: What Does This Mean for Crypto?

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

IMU

Imugene kicks off Australian trial for blood cancer treatment

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor